Mutations in HNRNPA1 encoding heterogeneous nuclear ribonucleoprotein (hnRNP) A1 are a rare cause of amyotrophic lateral sclerosis (ALS) and multisystem proteinopathy (MSP). hnRNPA1 is part of the group of RNA-binding proteins (RBPs) that assemble with RNA to form RNPs. hnRNPs are concentrated in the nucleus and function in pre-mRNA splicing, mRNA stability, and the regulation of transcription and translation. During stress, hnRNPs, mRNA, and other RBPs condense in the cytoplasm to form stress granules (SGs). SGs are implicated in the pathogenesis of (neuro-)degenerative diseases, including ALS and inclusion body myopathy (IBM). Mutations in RBPs that affect SG biology, including FUS, TDP-43, hnRNPA1, hnRNPA2B1, and TIA1, underlie ALS, IBM, and other neurodegenerative diseases. Here, we characterize 4 potentially novel HNRNPA1 mutations (yielding 3 protein variants: *321Eext*6, *321Qext*6, and G304Nfs*3) and 2 known HNRNPA1 mutations (P288A and D262V), previously connected to ALS and MSP, in a broad spectrum of patients with hereditary motor neuropathy, ALS, and myopathy. We establish that the mutations can have different effects on hnRNPA1 fibrillization, liquid-liquid phase separation, and SG dynamics. P288A accelerated fibrillization and decelerated SG disassembly, whereas *321Eext*6 had no effect on fibrillization but decelerated SG disassembly. By contrast, G304Nfs*3 decelerated fibrillization and impaired liquid phase separation. Our findings suggest different underlying pathomechanisms for HNRNPA1 mutations with a possible link to clinical phenotypes.
Danique Beijer, Hong Joo Kim, Lin Guo, Kevin O’Donovan, Inès Mademan, Tine Deconinck, Kristof Van Schil, Charlotte M. Fare, Lauren E. Drake, Alice F. Ford, Andrzej Kochański, Dagmara Kabzińska, Nicolas Dubuisson, Peter Van den Bergh, Nicol C. Voermans, Richard J.L.F. Lemmers, Silvère M. van der Maarel, Devon Bonner, Jacinda B. Sampson, Matthew T. Wheeler, Anahit Mehrabyan, Steven Palmer, Peter De Jonghe, James Shorter, J. Paul Taylor, Jonathan Baets
Title and authors | Publication | Year |
---|---|---|
Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD
Khalil B, Linsenmeier M, Smith CL, Shorter J, Rossoll W |
Molecular Neurodegeneration | 2024 |
Nuclear pore dysfunction and disease: a complex opportunity.
Fare CM, Rothstein JD |
Nucleus (Austin, Tex.) | 2024 |
A mutation in the low-complexity domain of splicing factor hnRNPA1 linked to amyotrophic lateral sclerosis disrupts distinct neuronal RNA splicing networks
Lee YJ, Rio DC |
Genes & development | 2024 |
Mutations in human prion-like domains: pathogenic but not always amyloidogenic.
Bartolomé-Nafría A, García-Pardo J, Ventura S |
Prion | 2024 |
Metastable condensates suppress conversion to amyloid fibrils.
Das T, Zaidi F, Farag M, Ruff KM, Messing J, Taylor JP, Pappu RV, Mittag T |
bioRxiv : the preprint server for biology | 2024 |
RNA modulates hnRNPA1A amyloid formation mediated by biomolecular condensates
Morelli C, Faltova L, Capasso Palmiero U, Makasewicz K, Papp M, Jacquat RP, Pinotsi D, Arosio P |
Nature Chemistry | 2024 |
HNRNPA1 de novo Variant Associated with Early Childhood Onset, Rapidly Progressive Generalized Myopathy.
Roos A, Häusler M, Kollipara L, Topf A, Preusse C, Stucka R, Nolte K, Strom T, Berutti R, Jiang X, Koll R, Lochmüller H, Schacht SM, Zahedi RP, Weis J, Senderek J |
Journal of neuromuscular diseases | 2024 |
Current advance on distal myopathy genetics
Ranta-aho J, Johari M, Udd B |
Current Opinion in Neurology | 2024 |
Axonopathy Underlying Amyotrophic Lateral Sclerosis: Unraveling Complex Pathways and Therapeutic Insights.
Luan T, Li Q, Huang Z, Feng Y, Xu D, Zhou Y, Hu Y, Wang T |
Neuroscience bulletin | 2024 |
Dominant stop-loss HNRNPA1 variants in juvenile-onset myopathy.
Turner J, Bruels CC, Daugherty AL, Estrella EA, Stafki S, Syeda SB, Littel HR, Pais L, Ganesh VS, Lidov HGW, Paine SML, Maddison P, Harrison RE, Straub V, Ghosh PS, Pacak CA, Kunkel LM, Draper I, Topf A, Kang PB |
Muscle & nerve | 2024 |
Nuclear functions regulated by the VRK1 kinase
Lazo PA |
Nucleus | 2024 |
Cryo-EM structure of hnRNPDL-2 fibrils, a functional amyloid associated with limb-girdle muscular dystrophy D3
Garcia-Pardo J, Bartolomé-Nafría A, Chaves-Sanjuan A, Gil-Garcia M, Visentin C, Bolognesi M, Ricagno S, Ventura S |
Nature Communications | 2023 |
The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases
Weng YT, Chang YM, Chern Y |
International journal of molecular sciences | 2023 |
C-terminal frameshift variant of TDP-43 with pronounced aggregation-propensity causes rimmed vacuole myopathy but not ALS/FTD.
Ervilha Pereira P, Schuermans N, Meylemans A, LeBlanc P, Versluys L, Copley KE, Rubien JD, Altheimer C, Peetermans M, Debackere E, Vanakker O, Janssens S, Baets J, Verhoeven K, Lammens M, Symoens S, De Paepe B, Barmada SJ, Shorter J, De Bleecker JL, Bogaert E, Dermaut B |
Acta Neuropathologica | 2023 |
Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy
Bagyinszky E, Hulme J, An SS |
Cells | 2023 |
Stress Granules as Causes and Consequences of Translation Suppression.
Baymiller M, Moon SL |
Antioxidants & Redox Signaling | 2023 |
Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis
Zhou W, Xu R |
Frontiers in neuroscience | 2023 |
Phase separation and pathologic transitions of RNP condensates in neurons: implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders
Naskar A, Nayak A, Salaikumaran MR, Vishal SS, Gopal PP |
Frontiers in molecular neuroscience | 2023 |
Cryo-EM structure of the full-length hnRNPA1 amyloid fibril
Sharma K, Banerjee S, Savran D, Rajes C, Wiese S, Girdhar A, Schwierz N, Lee C, Shorter J, Schmidt M, Guo L, Fändrich M |
Journal of Molecular Biology | 2023 |
The interface of condensates of the hnRNPA1 low-complexity domain promotes formation of amyloid fibrils
Linsenmeier M, Faltova L, Morelli C, Capasso Palmiero U, Seiffert C, Küffner AM, Pinotsi D, Zhou J, Mezzenga R, Arosio P |
Nature Chemistry | 2023 |
Nuclear pore pathology underlying multisystem proteinopathy type 3-related inclusion body myopathy.
Izumi R, Ikeda K, Niihori T, Suzuki N, Shirota M, Funayama R, Nakayama K, Warita H, Tateyama M, Aoki Y, Aoki M |
Annals of Clinical and Translational Neurology | 2023 |
Emerging Roles for Phase Separation of RNA-Binding Proteins in Cellular Pathology of ALS
K Milicevic, B Rankovic, P Andjus, D Bataveljic, D Milovanovic |
Frontiers in Cell and Developmental Biology | 2022 |
Heterozygous frameshift variants in HNRNPA2B1 cause early-onset oculopharyngeal muscular dystrophy
Kim HJ, Mohassel P, Donkervoort S, Guo L, O\u2019Donovan K, Coughlin M, Lornage X, Foulds N, Hammans SR, Foley AR, Fare CM, Ford AF, Ogasawara M, Sato A, Iida A, Munot P, Ambegaonkar G, Phadke R, O\u2019Donovan DG, Buchert R, Grimmel M, Töpf A, Zaharieva IT, Brady L, Hu Y, Lloyd TE, Klein A, Steinlin M, Kuster A, Mercier S, Marcorelles P, Péréon Y, Fleurence E, Manzur A, Ennis S, Upstill-Goddard R, Bello L, Bertolin C, Pegoraro E, Salviati L, French CE, Shatillo A, Raymond FL, Haack TB, Quijano-Roy S, Böhm J, Nelson I, Stojkovic T, Evangelista T, Straub V, Romero NB, Laporte J, Muntoni F, Nishino I, Tarnopolsky MA, Shorter J, Bönnemann CG, Taylor JP |
Nature Communications | 2022 |
Neuroprotective Effects of Celastrol in Neurodegenerative Diseases-Unscramble Its Major Mechanisms of Action and Targets
Liu D, Zhang Q, Luo P, Gu L, Shen S, Tang H, Zhang Y, Lyu M, Shi Q, Yang C, Wang J |
Aging and disease | 2022 |
Adult‐onset dominant muscular dystrophy in Greek families caused by Annexin A11
Johari M, Papadimas G, Papadopoulos C, Xirou S, Kanavaki A, Chrysanthou\u2010Piterou M, Rusanen S, Savarese M, Hackman P, Udd B |
Annals of Clinical and Translational Neurology | 2022 |
hnRNP A1 in RNA metabolism regulation and as a potential therapeutic target
Feng J, Zhou J, Lin Y, Huang W |
Frontiers in pharmacology | 2022 |
Clinical heterogeneity in a family with flail arm syndrome and review of hnRNPA1‐related spectrum
Han X, Zhan F, Yao Y, Cao L, Liu J, Yao S |
Annals of Clinical and Translational Neurology | 2022 |
A minimal construct of nuclear-import receptor Karyopherin-β2 defines the regions critical for chaperone and disaggregation activity
Fare CM, Rhine K, Lam A, Myong S, Shorter J |
The Journal of biological chemistry | 2022 |
Early onset hereditary neuronopathies: an update on non-5q motor neuron diseases
Zambon AA, Pini V, Bosco L, Falzone YM, Munot P, Muntoni F, Previtali SC |
Brain : a journal of neurology | 2022 |
Karyopherin-mediated nucleocytoplasmic transport.
Wing CE, Fung HYJ, Chook YM |
Nature reviews. Molecular cell biology | 2022 |
Dominant Distal Myopathy 3 (MPD3) Caused by a Deletion in the HNRNPA1 Gene
P Hackman, SM Rusanen, M Johari, A Vihola, PH Jonson, J Sarparanta, K Donner, P Lahermo, S Koivunen, H Luque, M Soininen, I Mahjneh, M Auranen, M Arumilli, M Savarese, B Udd |
Neurology Genetics | 2021 |
Pathological phase transitions in ALS-FTD impair dynamic RNA–protein granules
NB Nedelsky, JP Taylor |
RNA (New York, N.Y.) | 2021 |